Belgian clinical-stage biotech iTeos Therapeutics (Nasdaq: ITOS) saw its shar leap18.6% to $8.20 today, despite posting ...

Privately-held Remedy Plan Therapeutics, a US pharma company developing novel, hyperbolic NAMPT inhibitors, has raised more ...

Denmark’s Novo Nordisk has presented data at the European Congress of Obesity (ECO) showing that Wegovy (semaglutide ...

They are the two drugs of the moment, the weight loss products promising a miraculous solution to obesity and—in data ...

Swedish biotech Hansa Biopharma (Nasdaq Stockholm: HNSA) has appointed Maria Törnsén as chief operating officer and president ...

India has declined the UK's request to include a 'data exclusivity' clause in the proposed Free Trade Agreement (FTA), as ...

Swedish contract development and manufacturing firm Recipharm and France-based regulatory specialist ProductLife Group (PLG) ...

Swiss pharma giant Roche (ROG: SIX), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit ...

US biotech Genentech and its parent, Swiss pharma giant Roche (ROG: SIX), have announced plans to invest more than $700 ...

Hungary’s largest drugmaker Gedeon Richter (RICHT: HB) has announced its financial results for the first quarter of 2025, ...

US pharma stocks regained ground Monday after Donald Trump signed an executive order aiming to slash prescription drug prices ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Adzynma (apadamtase alfa/cinaxadamtase alfa; ...